首页|原发性皮肤淀粉样变的治疗研究进展

原发性皮肤淀粉样变的治疗研究进展

扫码查看
原发性皮肤淀粉样变是一种慢性瘙痒性皮肤病,常给患者的日常生活造成较大困扰.该病的治疗方法目前尚无统一标准,现有的治疗手段主要包括药物治疗、物理治疗及手术治疗三大类.然而,治疗方案的选择需依据患者症状的严重程度、个体差异及医师的临床经验来综合决定.随着研究的深入,新的治疗方法不断涌现,患者在治疗过程中需与医生密切配合,及时调整治疗方案.在制定个体化的治疗计划时,全面考虑患者的具体情况及长期管理是至关重要的.
Advances in the Treatment of Primary Cutaneous Amyloidosis
Primary cutaneous amyloidosis is a chronic pruritic dermatological condition that significantly impacts the physical and mental health of patients.Currently,there is no uniform recommendation for the treatment of this disease,and the available treatments mainly include three major categories:drug therapy,physical interventions,and surgical modalities.However,the selection of treatment options depends on the severity of the patient's symptoms,individual differences,and the physician's clinical experience.As scientific inquiry progresses,novel therapeutic approaches continue to emerge.Patients are urged to maintain close collaboration with healthcare professionals throughout the treatment process,facilitating timely adjustments to the treatment plan.Comprehensive consideration of the patient's specific situation and long-term management is essential when developing an individualized treatment plan.

Primary cutaneous amyloidosisTreatmentJAK inhibitorDupilumabLaser

邹攀、曹育春、张勇、朱小美

展开 >

华中科技大学同济医学院附属同济医院皮肤科,湖北 武汉 430030

原发性皮肤淀粉样变 治疗 JAK抑制剂 度普利尤单抗 激光

2024

皮肤科学通报
西安交通大学

皮肤科学通报

CSTPCD
影响因子:0.273
ISSN:1001-8077
年,卷(期):2024.41(1)
  • 17